News

Under the deal, the parties will explore and test the value of digital health solutions, mobile technologies and insights from advanced data analytics in the delivery of health

The PMA application seeks approval for tumor treating fields (TTFields), in combination with temozolomide chemotherapy, as a first-line treatment for glioblastoma (GBM). The submission of PMA is based

Objective of the project is to use power of the body’s own immune system to attack cancer cells and discover possible new treatment options for cancer patients. By

An upfront payment of $87.5m has been made by Pfizer for the minority equity interest and exclusive option. As part of the deal, Pfizer will make additional potential

The agency has acknowledged receipt of the application and will notify the company when the review process is completed. If the FDA grants orphan drug designation, Trevyent would

The deal will focus on the development of basic research including studies on pathogenesis and drug susceptibility of cancer by promoting exchanges among researchers, physicians, and others engaged

The agency lifted the clinical hold after reviewing additional information related to the product candidates’ delivery devices. The company said that the US clinical development of these product

The one-month, prospective, multicentre, open-label Phase II trial enrolled a total of 39 pediatric patients in the US and is designed to characterize safety, procedural factors and clinical

Zykadia is an oral, selective inhibitor of ALK, a gene that can fuse with others to form an abnormal fusion protein that promotes the development and growth of